Platinum’s Protein Power: A New Frontier in Overcoming Cancer Drug Resistance
The Platinum Advantage in Cancer Therapeutics In the relentless battle against cancer, multidrug resistance (MDR) remains one of the most…
The Platinum Advantage in Cancer Therapeutics In the relentless battle against cancer, multidrug resistance (MDR) remains one of the most…
A groundbreaking study has uncovered a previously unknown cellular recycling pathway that uses optineurin as an adaptor protein. This discovery reveals how cells selectively degrade proteins from the Golgi apparatus using specialized ubiquitin chains.
Researchers have identified a previously unknown mechanism for protein degradation within cells, according to a recent scientific report. The study reveals that optineurin functions as an adaptor protein in Golgi membrane-associated degradation (GOMED), providing new insights into how cells manage protein waste. This discovery represents what sources indicate is the third known mechanism of ubiquitin-mediated proteolysis, alongside the well-established proteasome and autophagy pathways.